Lung biomarkers could revolutionize pulmonary hypertension care
NCT ID NCT01961232
First seen Mar 22, 2026 · Last updated Apr 29, 2026 · Updated 3 times
Summary
This study looks at whether measuring certain substances in the blood across the lungs can help doctors choose better treatments for people with pulmonary hypertension (high blood pressure in the lungs). About 100 adults undergoing a standard heart-lung test will also have these biomarkers measured. The goal is to see if this extra information leads to more personalized therapy and improved outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.